spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Vion Pharmaceuticals 

 HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch
 HSMN NewsFeed - 7 Jan 2021
Veteran Biopharma Executive Dane D. Hallberg Launches MASORI Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2020
Avion Pharmaceuticals, LLC, to Expand Its Women's Healthcare Portfolio of Products
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2018
Akero Therapeutics Appoints Mark Iwicki to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Jul 2018
Torque Appoints James Mullen as Chairman of Board of Directors, Maykin Ho, PhD, as Strategic Advisor to the Board of Directors, and Mario Sznol, MD, to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 31 Mar 2017
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Apr 2016
Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 8 Dec 2015
Pulmatrix Appoints Mark Iwicki Chairman of the Board
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jul 2014
CutisPharma Appoints Neal Muni, MD, MSPH as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2014
Mike Sullivan named President of Avion Pharmaceuticals, LLC
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 22 Oct 2013
Neos Therapeutics, Inc. Announces the Appointment of Vipin K. Garg, Ph.D. as Chief Executive Officer and Board Director
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2012
Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 2 Jul 2012
Cubist Pharmaceuticals Announces Senior Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2012
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 30 Dec 2009
Vion Pharmaceuticals Announces FDA Conclusion
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Dec 2008
Vion Pharmaceuticals Adds Tanya Lewis to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2008
Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2008
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine(R) (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2007
Vion Announces Suspension of Phase III Trial in Relapsed AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Apr 2007
Dr. James Tanguay Joins Vion Pharmaceuticals' Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
Vion Pharmaceuticals Enters Into Manufacturing Agreement for Cloretazine(R) (VNP40101M) With Ben Venue Laboratories
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Vion Pharmaceuticals Reaches Midpoint of Patient Accrual to Cloretazine(R) (VNP40101M) Phase III Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Oct 2006
Vion Pharmaceuticals Presents Initial Data From a Phase II Trial of Cloretazine(R) (VNP40101M) in Patients With Relapsed or Refractory Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jul 2006
Aileen Ryan Joins Vion Pharmaceuticals' Senior Management Team
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2006
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2006
Vion Initiates Pivotal Phase II Trial of Single Agent Cloretazine(R) in Elderly Patients with De Novo Poor-Risk Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Mar 2006
Schering-Plough Announces Changes In Executive Finance Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2006
Vion Pharmaceuticals Announces Plans to Conduct a Pivotal Phase II Trial of Cloretazine(R) in Elderly Poor-Risk Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jan 2006
Vion Pharmaceuticals Receives Orphan Drug Designation for Cloretazine(R) in Europe for Treatment of Acute Myeloid Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Jan 2006
Meghan Fitzgerald Joins Vion's Senior Management Team
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
Vion Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.